Interagency Patent Coordination and Improvement Act of 2025

Bill 119 s 1097, also known as the "Interagency Task Force on Patents and FDA Collaboration Act," aims to amend title 35 of the United States Code to create a partnership between the United States Patent and Trademark Office (USPTO) and the Food and Drug Administration (FDA). The main goal of this bill is to facilitate the sharing of information and technical assistance between these two agencies in relation to patents.

The bill proposes the establishment of an interagency task force that will be responsible for coordinating efforts between the USPTO and FDA. This task force will work towards improving communication and collaboration between the two agencies, with the ultimate aim of streamlining the patent process for products regulated by the FDA.

Additionally, the bill outlines the specific responsibilities of the task force, which include sharing information on patent applications related to FDA-regulated products, providing technical assistance to patent examiners and FDA reviewers, and identifying areas where the patent and regulatory processes can be harmonized. Overall, the Interagency Task Force on Patents and FDA Collaboration Act seeks to enhance cooperation between the USPTO and FDA in order to promote innovation, protect intellectual property rights, and ensure the safety and efficacy of FDA-regulated products.